SLC5A2 and disorder of glycogen metabolism: EuDKA was once considered a rare phenomenon but has become more commonly recognized, especially with the growing use of newer antidiabetic medications, particularly sodium-glucose cotransporter-2 (SGLT2) inhibitors, as well as recent insulin use, reduced caloric intake, heavy alcohol consumption, chronic liver disease, and glycogen storage disorders.[2]